These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9096280)

  • 1. Alterations in epidermal growth factor binding to hepatic membranes following dietary exposure of rats to known hepatocarcinogens.
    Ringer DP; Panzeter PL; DeCicco LA
    Toxicol Lett; 1997 Mar; 91(1):7-12. PubMed ID: 9096280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.
    Hasegawa R; Mutai M; Imaida K; Tsuda H; Yamaguchi S; Ito N
    Jpn J Cancer Res; 1989 Oct; 80(10):945-51. PubMed ID: 2482284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the binding capacity of hepatic membranes for epidermal growth factor during multistage hepatocarcinogenesis in rats.
    DeCicco LA; Panzeter PL; Cashman RE; Ringer DP
    Biochem Biophys Res Commun; 1996 Nov; 228(1):69-74. PubMed ID: 8912637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of selected hepatocarcinogens on polyribosomes and protein synthesis in the livers of rats fed purified diets containing hepatocarcinogens.
    Sidransky H; Verney E
    Cancer Res; 1978 Apr; 38(4):1166-72. PubMed ID: 639043
    [No Abstract]   [Full Text] [Related]  

  • 5. Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity.
    Ringer DP; Norton TR
    Carcinogenesis; 1987 Nov; 8(11):1749-52. PubMed ID: 3478156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of high-molecular-weight proteins in liver microsomes of rats treated with hepatocarcinogens.
    Khongwir BS; Dani HM; Dhanda JS
    J Environ Pathol Toxicol Oncol; 1997; 16(1):27-31. PubMed ID: 9256929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.
    Smith LD; Emerson RL; Nixon LK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2132-8. PubMed ID: 445410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene: ligand binding and autophosphorylation.
    Hwang DL; Roitman A; Carr BI; Barseghian G; Lev-Ran A
    Cancer Res; 1986 Apr; 46(4 Pt 2):1955-9. PubMed ID: 3004714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of 2-acetylaminofluorene-induced loss of nuclear envelope cytochrome P450 by the simultaneous administration of 3-methylcholanthrene.
    Carubelli R; Graham SA; McCay PB; Friedman FK
    Biochem Pharmacol; 1991 May; 41(9):1331-4. PubMed ID: 2018565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose and sex dependent effects of 2-acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene and DL-ethionine in induction of gamma-glutamyl transpeptidase-positive liver cell foci in rats.
    Tamano S; Tsuda H; Fukushima S; Masui T; Hosoda K; Ito N
    Cancer Lett; 1983 Oct; 20(3):313-21. PubMed ID: 6138146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of expression of ornithine decarboxylase mRNAs in rat liver after acute administration of hepatocarcinogens.
    Lorenzini EC; Buccellato FR; Scalabrino G
    Carcinogenesis; 1996 Jun; 17(6):1323-9. PubMed ID: 8681450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Kiehlbauch CC; Kosanke SD; Ringer DP
    Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcinogenesis in rat.
    DeCicco LA; Kong J; Ringer DP
    Cancer Lett; 1997 Jan; 111(1-2):149-56. PubMed ID: 9022140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism.
    Gradelet S; Le Bon AM; Bergès R; Suschetet M; Astorg P
    Carcinogenesis; 1998 Mar; 19(3):403-11. PubMed ID: 9525273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene.
    Ringer DP; Norton TR; Cox B; Howell BA
    Cancer Lett; 1988 Jun; 40(3):247-55. PubMed ID: 3164251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Methylcholanthrene-inhibition of hepatocarcinogenesis in the rat due to 3'-methyl-4-dimethylaminoazobenzene or 2-acetylamino-fluorene: a comparative study.
    Flaks A; Flaks B
    Carcinogenesis; 1982; 3(9):981-91. PubMed ID: 6814780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatocarcinogens on epoxide hydrolase and other xenobiotic metabolizing enzymes.
    Dent JG; Graichen ME
    Carcinogenesis; 1982; 3(7):733-8. PubMed ID: 7116569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.
    Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA
    Toxicol Appl Pharmacol; 2009 Mar; 235(3):305-11. PubMed ID: 19167416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a marginally lipotrope-deficient diet on the hepatic levels of S-adenosylmethionine and on the urinary metabolites of 2-acetylaminofluorene in rats.
    Poirier LA; Grantham PH; Rogers AE
    Cancer Res; 1977 Mar; 37(3):744-8. PubMed ID: 65217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose responses of five hepatocarcinogens for the initiation of rat hepatocarcinogenesis.
    Imaida K; Shirai T; Tatematsu M; Takano T; Ito N
    Cancer Lett; 1981 Dec; 14(3):279-83. PubMed ID: 6800641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.